Patients with refractory Crohn’s disease who previously received ustekinumab experienced clinical and endoscopic improvements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback